A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis

Mise à jour : Il y a 5 ans
Référence : NCT00812799

Femme et Homme

Extrait

This study will be performed to determine the long-term efficacy of 19.000 BU Oralgen grass pollen administered daily in patients with grass pollen related allergic rhinoconjunctivitis.


Critère d'inclusion

  • Allergic Rhinoconjunctivitis


Liens